146 related articles for article (PubMed ID: 22127786)
1. Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health.
Cooperstein E; Gilbert J; Epstein JB; Dietrich MS; Bond SM; Ridner SH; Wells N; Cmelak A; Murphy BA
Head Neck; 2012 Jun; 34(6):797-804. PubMed ID: 22127786
[TBL] [Abstract][Full Text] [Related]
2. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment.
Kolnick L; Deng J; Epstein JB; Migliorati CA; Rezk J; Dietrich MS; Murphy BA
Oral Oncol; 2014 Feb; 50(2):135-40. PubMed ID: 24239279
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation.
Murphy BA; Dietrich MS; Wells N; Dwyer K; Ridner SH; Silver HJ; Gilbert J; Chung CH; Cmelak A; Burkey B; Yarbrough WG; Sinard R; Netterville J
Head Neck; 2010 Jan; 32(1):26-37. PubMed ID: 19626644
[TBL] [Abstract][Full Text] [Related]
4. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
[TBL] [Abstract][Full Text] [Related]
5. Symptom burden in head and neck cancer: impact upon oral energy and protein intake.
Ganzer H; Touger-Decker R; Parrott JS; Murphy BA; Epstein JB; Huhmann MB
Support Care Cancer; 2013 Feb; 21(2):495-503. PubMed ID: 22825457
[TBL] [Abstract][Full Text] [Related]
6. The Vanderbilt Head and Neck Symptom Survey Brazilian Portuguese version 2.0 (VHNSS 2.0): psychometric properties for patients with head and neck cancer who have undergone radiotherapy.
Barroso EM; Carvalho AL; Paiva CE; Murphy BA; Paiva BS
BMC Res Notes; 2015 Oct; 8():522. PubMed ID: 26428472
[TBL] [Abstract][Full Text] [Related]
7. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
8. Preliminary Testing of a Patient-Reported Outcome Measure for Recurrent or Metastatic Head and Neck Cancer.
Jackson LK; Deng J; Ridner SH; Gilbert J; Dietrich MS; Murphy BA
Am J Hosp Palliat Care; 2016 May; 33(4):313-20. PubMed ID: 25667146
[TBL] [Abstract][Full Text] [Related]
9. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.
Kraaijenga SA; van der Molen L; Jacobi I; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3521-31. PubMed ID: 25381096
[TBL] [Abstract][Full Text] [Related]
10. The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review.
Bressan V; Stevanin S; Bianchi M; Aleo G; Bagnasco A; Sasso L
Cancer Treat Rev; 2016 Apr; 45():105-19. PubMed ID: 27010487
[TBL] [Abstract][Full Text] [Related]
11. Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.
van der Molen L; van Rossum MA; Jacobi I; van Son RJ; Smeele LE; Rasch CR; Hilgers FJ
J Voice; 2012 Sep; 26(5):664.e25-33. PubMed ID: 22209059
[TBL] [Abstract][Full Text] [Related]
12. Speech and swallowing rehabilitation following head and neck cancer: are we hearing the patient's voice? Our experience with ten patients.
Govender R; Breeson L; Tuomainen J; Smith CH
Clin Otolaryngol; 2013 Oct; 38(5):433-7. PubMed ID: 23890369
[No Abstract] [Full Text] [Related]
13. Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy.
Kraaijenga SA; Oskam IM; van Son RJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW; van der Molen L
Oral Oncol; 2016 Apr; 55():24-30. PubMed ID: 26874554
[TBL] [Abstract][Full Text] [Related]
14. Dysphagia and Oral Morbidities in Chemoradiation-Treated Head and Neck Cancer Patients.
Ihara Y; Crary MA; Madhavan A; Gregorio DC; Im I; Ross SE; Carnaby GD
Dysphagia; 2018 Dec; 33(6):739-748. PubMed ID: 29619560
[TBL] [Abstract][Full Text] [Related]
15. Development of an oral assessment tool to evaluate appetite in patients with head and neck cancer receiving radiotherapy.
Ogama N; Ogama N
Eur J Oncol Nurs; 2013 Aug; 17(4):474-81. PubMed ID: 23164924
[TBL] [Abstract][Full Text] [Related]
16. Translation and cross-cultural adaption of the Chinese version of the Vanderbilt Head and Neck Symptom Survey version 2.0: a tool for oral symptom assessment in head and neck cancer patients.
Jin M; Sun L; Meng R; Wang W; Sun R; Huang J; Qin Y; Wu B; Ding Q; Peng G; Zhang T; Yang K
Health Qual Life Outcomes; 2021 Jan; 19(1):27. PubMed ID: 33478530
[TBL] [Abstract][Full Text] [Related]
17. Association of age and symptom burden in patients with head and neck cancer.
Bond SM; Dietrich MS; Murphy BA
ORL Head Neck Nurs; 2011; 29(1):8-14. PubMed ID: 21473333
[TBL] [Abstract][Full Text] [Related]
18. Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
van der Laan HP; Bijl HP; Steenbakkers RJ; van der Schaaf A; Chouvalova O; Vemer-van den Hoek JG; Gawryszuk A; van der Laan BF; Oosting SF; Roodenburg JL; Wopken K; Langendijk JA
Radiother Oncol; 2015 Apr; 115(1):56-62. PubMed ID: 25792467
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
20. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
